Article
The effect of NOD2 on the microbiota in Crohn's disease.
Current opinion in biotechnology - 1 Aug 2016
Lauro Mackenzie L, Burch Jason M, Grimes Catherine Leimkuhler
Abstract excerpt
Recent advancements toward the treatment of Crohn's disease (CD) indicate great promise for long-term remission. CD patients suffer from a complex host of dysregulated interactions between their innate immune system and microbiome. The most predominant link to the onset of CD is a genetic mutation in the innate immune receptor nucleotide-binding oligomerization domain-containing 2 (NOD2). NOD2 responds to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
